Literature DB >> 26548485

Melanoma Incidence and Lethality Is Increased Following Solid Organ Transplantation.

David C Whiteman1, Catherine M Olsen2.   

Abstract

Organ transplants save lives, but the risks of adverse health outcomes remain high. Robbins et al. (2015) report the findings of a record-linkage study that followed almost 140,000 organ transplant recipients (OTRs) for melanoma. They found higher risk of incident melanoma among OTRs and markedly increased lethality. Education and surveillance are key to mitigating these effects.

Entities:  

Mesh：

Year:  2015        PMID： 26548485     DOI： 10.1038/jid.2015.326

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


  21 in total

Review 1.  Overdiagnosis in cancer.

Authors:  H Gilbert Welch; William C Black
Journal:  J Natl Cancer Inst       Date:  2010-04-22       Impact factor: 13.506

2.  Melanoma and non-melanoma skin cancer in inflammatory bowel disease patients following tumor necrosis factor-α inhibitor monotherapy and in combination with thiopurines: analysis of the Food and Drug Administration Adverse Event Reporting System.

Authors:  Michael R McKenna; Derrick J Stobaugh; Parakkal Deepak
Journal:  J Gastrointestin Liver Dis       Date:  2014-09       Impact factor: 2.008

3.  Melanoma research gathers momentum.

Authors: 
Journal:  Lancet       Date:  2015-06-13       Impact factor: 79.321

Review 4.  Increased risk of melanoma in organ transplant recipients: systematic review and meta-analysis of cohort studies.

Authors:  Adèle C Green; Catherine M Olsen
Journal:  Acta Derm Venereol       Date:  2015-11       Impact factor: 4.437

5.  Long-term cancer risk of immunosuppressive regimens after kidney transplantation.

Authors:  Martin P Gallagher; Patrick J Kelly; Meg Jardine; Vlado Perkovic; Alan Cass; Jonathan C Craig; Josette Eris; Angela C Webster
Journal:  J Am Soc Nephrol       Date:  2010-04-29       Impact factor: 10.121

6.  Malignancy after renal transplantation in the new era of immunosuppression.

Authors:  Ewa Watorek; Maria Boratynska; Danuta Smolska; Dariusz Patrzalek; Marian Klinger
Journal:  Ann Transplant       Date:  2011 Apr-Jun       Impact factor: 1.530

7.  Targeting oncogenic drivers and the immune system in melanoma.

Authors:  Grant A McArthur; Antoni Ribas
Journal:  J Clin Oncol       Date:  2012-12-17       Impact factor: 44.544

8.  Cutaneous melanoma is related to immune suppression in kidney transplant recipients.

Authors:  Claire M Vajdic; Marina T van Leeuwen; Angela C Webster; Margaret R E McCredie; John H Stewart; Jeremy R Chapman; Janaki Amin; Stephen P McDonald; Andrew E Grulich
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-07-21       Impact factor: 4.254

9.  Spectrum of cancer risk among US solid organ transplant recipients.

Authors:  Eric A Engels; Ruth M Pfeiffer; Joseph F Fraumeni; Bertram L Kasiske; Ajay K Israni; Jon J Snyder; Robert A Wolfe; Nathan P Goodrich; A Rana Bayakly; Christina A Clarke; Glenn Copeland; Jack L Finch; Mary Lou Fleissner; Marc T Goodman; Amy Kahn; Lori Koch; Charles F Lynch; Margaret M Madeleine; Karen Pawlish; Chandrika Rao; Melanie A Williams; David Castenson; Michael Curry; Ruth Parsons; Gregory Fant; Monica Lin
Journal:  JAMA       Date:  2011-11-02       Impact factor: 157.335

Review 10.  Risk of melanoma in people with HIV/AIDS in the pre- and post-HAART eras: a systematic review and meta-analysis of cohort studies.

Authors:  Catherine M Olsen; Lani L Knight; Adèle C Green
Journal:  PLoS One       Date:  2014-04-16       Impact factor: 3.240
View more
  1 in total

1.  Assessing the Potential for Patient-led Surveillance After Treatment of Localized Melanoma (MEL-SELF): A Pilot Randomized Clinical Trial.

Authors:  Deonna M Ackermann; Mbathio Dieng; Ellie Medcalf; Marisa C Jenkins; Cathelijne H van Kemenade; Monika Janda; Robin M Turner; Anne E Cust; Rachael L Morton; Les Irwig; Pascale Guitera; H Peter Soyer; Victoria Mar; Jolyn K Hersch; Donald Low; Cynthia Low; Robyn P M Saw; Richard A Scolyer; Dorothy Drabarek; David Espinoza; Anthony Azzi; Alister M Lilleyman; Amelia K Smit; Peter Murchie; John F Thompson; Katy J L Bell
Journal:  JAMA Dermatol       Date:  2022-01-01       Impact factor: 11.816
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.